PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31472963-4	2019	In contrast, Prx2 was highly sensitive to the relatively hydrophobic oxidants, such as tert-butyl hydroperoxide (t-BHP) and cumene hydroperoxide.	tert-Butylhydroperoxide	87-111	peroxiredoxin 2	Homo sapiens	13-17	
31472963-4	2019	In contrast, Prx2 was highly sensitive to the relatively hydrophobic oxidants, such as tert-butyl hydroperoxide (t-BHP) and cumene hydroperoxide.	tert-Butylhydroperoxide	113-118	peroxiredoxin 2	Homo sapiens	13-17	
31472963-6	2019	The t-BHP treatment formed hyperoxidized Prx2 in a dose-dependent manner.	tert-Butylhydroperoxide	4-9	peroxiredoxin 2	Homo sapiens	41-45	
25379381-0	2014	Irreversible hyperoxidation of peroxiredoxin 2 is caused by tert-butyl hydroperoxide in human red blood cells.	tert-Butylhydroperoxide	60-84	peroxiredoxin 2	Homo sapiens	31-46	
28434171-0	2017	Peroxidatic cysteine residue of peroxiredoxin 2 separated from human red blood cells treated by tert-butyl hydroperoxide is hyperoxidized into sulfinic and sulfonic acids.	tert-Butylhydroperoxide	96-120	peroxiredoxin 2	Homo sapiens	32-47	
28434171-4	2017	The LC-MS/MS analysis of the trypsin digests of Prx2 fractionated by reverse-phase HPLC demonstrated that the cysteine-51 residue (Cys-51) of the protein was modified with the hyperoxidative functional groups, sulfinic acid (-SO2H) and sulfonic acid (-SO3H), in RBCs treated with tert-butyl hydroperoxide (t-BHP).	tert-Butylhydroperoxide	280-304	peroxiredoxin 2	Homo sapiens	48-52	
28434171-4	2017	The LC-MS/MS analysis of the trypsin digests of Prx2 fractionated by reverse-phase HPLC demonstrated that the cysteine-51 residue (Cys-51) of the protein was modified with the hyperoxidative functional groups, sulfinic acid (-SO2H) and sulfonic acid (-SO3H), in RBCs treated with tert-butyl hydroperoxide (t-BHP).	tert-Butylhydroperoxide	306-311	peroxiredoxin 2	Homo sapiens	48-52	
25379381-3	2014	The detection of a peak corresponding to Prx2-SO2/3 was clearly observed following treatment of tert-butyl hydroperoxide (t-BHP), but not H2O2, and was found to be dose-dependent.	tert-Butylhydroperoxide	96-120	peroxiredoxin 2	Homo sapiens	41-45	
25379381-3	2014	The detection of a peak corresponding to Prx2-SO2/3 was clearly observed following treatment of tert-butyl hydroperoxide (t-BHP), but not H2O2, and was found to be dose-dependent.	tert-Butylhydroperoxide	122-127	peroxiredoxin 2	Homo sapiens	41-45	
22916248-13	2012	Silencing PRDX2 in moDCs by means of siRNA significantly increased CM-DCF fluorescence and cell death upon tert-BHP-stimulation.	tert-Butylhydroperoxide	107-115	peroxiredoxin 2	Homo sapiens	10-15